Ionis Pharmaceuticals, Inc.

IONS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$454-$366-$270-$29
Dep. & Amort.$20$22$22$20
Deferred Tax$0$0$0$25
Stock-Based Comp.$130$106$100$121
Change in WC-$209-$77$8-$114
Other Non-Cash$12$8-$135$8
Operating Cash Flow-$501-$308-$274$31
Investing Activities
PP&E Inv.-$45-$24-$20-$18
Net Acquisitions$0$0$254$6
Inv. Purchases-$1,853-$1,771-$1,486-$1,131
Inv. Sales/Matur.$1,769$1,585$989$1,344
Other Inv. Act.-$5-$4$0-$6
Investing Cash Flow-$134-$214-$263$195
Financing Activities
Debt Repay.-$45$87-$51$314
Stock Issued$523$49$6$12
Stock Repurch.$0$0-$11-$17
Dividends Paid$0$0$0$0
Other Fin. Act.$0$508-$11-$79
Financing Cash Flow$478$644-$55$246
Forex Effect-$0$0-$0-$0
Net Chg. in Cash-$157$123-$593$472
Supplemental Information
Beg. Cash$399$276$869$398
End Cash$242$399$276$869
Free Cash Flow-$546-$336-$294$13